The new pre-fabricated G-CON PODs, along with Comecer’s closed aseptic solutions reduce budget and facility constraints by providing readily deployable, […]
Maximize the efficiency of your Pharma & Radiopharma Production Plant with Illuminate™ Manufacturing Intelligence, now available for Comecer single isolators […]
NASA visited Thales Alenia Space, Italy (TASI-I) facilities and was amazed at the technology that Comecer provided with its ultra-clean […]
A guide for your production plant’s digital transformation Smart factories are predicted to deliver 500 billion US dollars in value […]
Comecer announces its support of Serum Institute of India Pvt. Ltd (vaccine manufacturer) in the global fight against dangerous diseases. […]
At the Toulouse Oncopole University Cancer Institute, a new milestone in research has just been reached. A patient with head […]
GlaxoSmithKline is one of the two winning companies in the Social Impact category for the ISPE “Facility of the […]
Interesting video, tell me more » Combo Phill™ is our new Aseptic Filling Line for Vials and Syringes Compact, flexible, […]
Potent-API processing isolator Watch the NEW Comecer PAPI for containment requirements for pharmaceutical companies that require high-level protection during potent […]
Long-life for respirator masks: the reuse of FFP3/FFP2/N95, and other devices can be a new perspective good for the planet […]
Take a virtual tour of Comecer HQ You can see the development and production of high technology systems in the […]
Is your company focusing its efforts on vaccine production? Comecer is ready to supply equipment for vaccine research and production. […]
H2O2 “Ultra-Low concentration” investigations on sterile pharmaceutical products Vapour Phase Hydrogen Peroxide (VPHP) is largely exploited as a sterilization agent […]
In COMECER, we take customer feedback seriously. That is why mock-up testing is one of the key steps in the […]
A BATCH APPROACH FOR PATIENT SPECIFIC ONCOLOGY DRUGS Oncology drugs compounding Pharmacy Compounding is the creation of a personalized drug […]